6-Bromo-5-methoxypyridin-3-amine, 95.0%, 250mg

C70 Fullerene, 95%, 100mg

3-Fluoro-5-methylphenol, 98.0%, 1g

N'-(2-METHOXYPHENYL)ACETOHYDRAZIDE, 95.0%, 1g

4-Oxo-3,4-dihydrothieno[2,3-d]pyrimidine-5-carbonitrile, 97.0%, 250mg

1-(3,4-dichlorophenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

Boc-D-Homoserine, 95.0%, 1g

4-Bromo-2,5-difluoroiodobenzene, 95.0%, 5g

5-bromoindol, mínimo 99,5 %, 25 g, envase de vidrio

2-(3-Oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid, 95.0%, 5g

4,5-Dimethoxy-2-nitroaniline, 97%, 100mg

4-(2-Methyl-1h-imidazol-1-yl)pyridin-3-amine, 95%, 100mg

Methyl 2-Chloro-4-fluorobenzoate>98.0%(GC)5g